Table 1.
The number and the relative proportion of different β-thalassemia mutations identified in the current study
| Mutation | Phenotype | No. (%) | Origin |
|---|---|---|---|
| IVS-I-110 (G>A) | β+ | 32 (34.0) | Mediterranean |
| IVS-I-6 (T>C) | β+ | 9 (9.6) | Mediterranean |
| IVS-I- 5 (G>C) | β+ | 8 (8.5) | Asian Indian |
| Codon 44 (−C) | βo | 7 (7.4) | Kurdish |
| Codon 39 (C>T) | βo | 7 (7.4) | Mediterranean |
| IVS-I-1 (G>A) | βo | 6 (6.4) | Mediterranean |
| IVS-II-1(G>A) | βo | 6 (6.4) | Mediterranean |
| Codon 8 (−AA) | βo | 5 (5.3) | Turkish |
| IVS-I-130 (G>C) | βo | 3 (3.2) | Turkish |
| Codon 5 (−CT) | βo | 3 (3.2) | Mediterranean |
| IVS-II-745 (C>G) | β+ | 2 (2.1) | Mediterranean |
| Uncharacterized | 6 (6.4) |